
Patrick James Orme
Examiner (ID: 13431, Phone: (313)446-4911 , Office: P/1779 )
| Most Active Art Unit | 1779 |
| Art Unit(s) | 1779 |
| Total Applications | 542 |
| Issued Applications | 301 |
| Pending Applications | 62 |
| Abandoned Applications | 193 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4989344
[patent_doc_number] => 20070155685
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-05
[patent_title] => 'Pharmaceutical composition'
[patent_app_type] => utility
[patent_app_number] => 10/591048
[patent_app_country] => US
[patent_app_date] => 2005-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 27643
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20070155685.pdf
[firstpage_image] =>[orig_patent_app_number] => 10591048
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/591048 | Pharmaceutical composition | Feb 27, 2005 | Abandoned |
Array
(
[id] => 6952237
[patent_doc_number] => 20050227331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-13
[patent_title] => 'Conjoined polynucleotide catalysts'
[patent_app_type] => utility
[patent_app_number] => 11/054106
[patent_app_country] => US
[patent_app_date] => 2005-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13017
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20050227331.pdf
[firstpage_image] =>[orig_patent_app_number] => 11054106
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/054106 | Conjoined polynucleotide catalysts | Feb 8, 2005 | Abandoned |
Array
(
[id] => 7233172
[patent_doc_number] => 20050256072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-17
[patent_title] => 'Dual functional oligonucleotides for use in repressing mutant gene expression'
[patent_app_type] => utility
[patent_app_number] => 11/055035
[patent_app_country] => US
[patent_app_date] => 2005-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 16646
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20050256072.pdf
[firstpage_image] =>[orig_patent_app_number] => 11055035
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/055035 | Dual functional oligonucleotides for use in repressing mutant gene expression | Feb 8, 2005 | Abandoned |
Array
(
[id] => 5225016
[patent_doc_number] => 20070254282
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-01
[patent_title] => 'Catalytic Polynucleotide and Its Use for Determination of Analytes'
[patent_app_type] => utility
[patent_app_number] => 10/588153
[patent_app_country] => US
[patent_app_date] => 2005-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 10221
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20070254282.pdf
[firstpage_image] =>[orig_patent_app_number] => 10588153
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/588153 | Catalytic Polynucleotide and Its Use for Determination of Analytes | Jan 26, 2005 | Abandoned |
Array
(
[id] => 7172165
[patent_doc_number] => 20050203044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Small-mer compositions and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/043673
[patent_app_country] => US
[patent_app_date] => 2005-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 22604
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20050203044.pdf
[firstpage_image] =>[orig_patent_app_number] => 11043673
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/043673 | Small-mer compositions and methods of use | Jan 25, 2005 | Abandoned |
Array
(
[id] => 5769095
[patent_doc_number] => 20060019912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => 'Cell transfecting formulations of small interfering RNA related compositions and methods of making and use'
[patent_app_type] => utility
[patent_app_number] => 11/018888
[patent_app_country] => US
[patent_app_date] => 2004-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14489
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20060019912.pdf
[firstpage_image] =>[orig_patent_app_number] => 11018888
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/018888 | Cell transfecting formulations of small interfering RNA related compositions and methods of making and use | Dec 19, 2004 | Abandoned |
Array
(
[id] => 6918082
[patent_doc_number] => 20050095643
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-05
[patent_title] => 'Method of generating conditionally expressed mutant cells using expressible antisense sequences'
[patent_app_type] => utility
[patent_app_number] => 11/017379
[patent_app_country] => US
[patent_app_date] => 2004-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10877
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20050095643.pdf
[firstpage_image] =>[orig_patent_app_number] => 11017379
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/017379 | Method of generating conditionally expressed mutant cells using expressible antisense sequences | Dec 19, 2004 | Abandoned |
Array
(
[id] => 6997381
[patent_doc_number] => 20050137159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-23
[patent_title] => 'Methods compositions and articles of manufacture for modulating bone growth'
[patent_app_type] => utility
[patent_app_number] => 11/003939
[patent_app_country] => US
[patent_app_date] => 2004-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 19010
[patent_no_of_claims] => 80
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20050137159.pdf
[firstpage_image] =>[orig_patent_app_number] => 11003939
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/003939 | Methods compositions and articles of manufacture for modulating bone growth | Dec 5, 2004 | Issued |
Array
(
[id] => 6983267
[patent_doc_number] => 20050153337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-14
[patent_title] => 'iRNA conjugates'
[patent_app_type] => utility
[patent_app_number] => 11/004379
[patent_app_country] => US
[patent_app_date] => 2004-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 81769
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20050153337.pdf
[firstpage_image] =>[orig_patent_app_number] => 11004379
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/004379 | iRNA conjugates | Dec 2, 2004 | Abandoned |
Array
(
[id] => 7020052
[patent_doc_number] => 20050222071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Topical administration of at least one double-stranded RNA oligonucleotide (dsRNA)'
[patent_app_type] => utility
[patent_app_number] => 11/001085
[patent_app_country] => US
[patent_app_date] => 2004-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10139
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20050222071.pdf
[firstpage_image] =>[orig_patent_app_number] => 11001085
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/001085 | Topical administration of at least one double-stranded RNA oligonucleotide (dsRNA) | Dec 1, 2004 | Abandoned |
Array
(
[id] => 6944394
[patent_doc_number] => 20050196443
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-08
[patent_title] => 'Pulsatile release compositions and methods for enhanced intestinal drug absorption'
[patent_app_type] => utility
[patent_app_number] => 11/000814
[patent_app_country] => US
[patent_app_date] => 2004-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 20393
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20050196443.pdf
[firstpage_image] =>[orig_patent_app_number] => 11000814
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/000814 | Pulsatile release compositions and methods for enhanced intestinal oligonucleotide drug absorption | Nov 30, 2004 | Issued |
Array
(
[id] => 7111073
[patent_doc_number] => 20050208528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Enhancement of the stability of oligonucleotides comprising phosphorothioate linkages by addition of water-soluble antioxidants'
[patent_app_type] => utility
[patent_app_number] => 10/997221
[patent_app_country] => US
[patent_app_date] => 2004-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17149
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20050208528.pdf
[firstpage_image] =>[orig_patent_app_number] => 10997221
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/997221 | Enhancement of the stability of oligonucleotides comprising phosphorothioate linkages by addition of water-soluble antioxidants | Nov 23, 2004 | Abandoned |
Array
(
[id] => 7233141
[patent_doc_number] => 20050256069
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-17
[patent_title] => 'IRNA agents with biocleavable tethers'
[patent_app_type] => utility
[patent_app_number] => 10/985426
[patent_app_country] => US
[patent_app_date] => 2004-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 63422
[patent_no_of_claims] => 101
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20050256069.pdf
[firstpage_image] =>[orig_patent_app_number] => 10985426
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/985426 | IRNA agents with biocleavable tethers | Nov 8, 2004 | Issued |
Array
(
[id] => 5807671
[patent_doc_number] => 20060094025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Methods for detection of microrna molecules'
[patent_app_type] => utility
[patent_app_number] => 10/979052
[patent_app_country] => US
[patent_app_date] => 2004-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8438
[patent_no_of_claims] => 81
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20060094025.pdf
[firstpage_image] =>[orig_patent_app_number] => 10979052
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/979052 | Methods for detection of microrna molecules | Nov 1, 2004 | Abandoned |
Array
(
[id] => 7110696
[patent_doc_number] => 20050208151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Treatment of rheumatoid arthritis with FLIP antagonists'
[patent_app_type] => utility
[patent_app_number] => 10/980145
[patent_app_country] => US
[patent_app_date] => 2004-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 16189
[patent_no_of_claims] => 99
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20050208151.pdf
[firstpage_image] =>[orig_patent_app_number] => 10980145
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/980145 | Treatment of rheumatoid arthritis with FLIP antagonists | Oct 31, 2004 | Abandoned |
Array
(
[id] => 236321
[patent_doc_number] => 07595302
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-29
[patent_title] => 'Nucleic acids useful for triggering tumor cell lethality'
[patent_app_type] => utility
[patent_app_number] => 10/576818
[patent_app_country] => US
[patent_app_date] => 2004-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 13
[patent_no_of_words] => 9627
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/595/07595302.pdf
[firstpage_image] =>[orig_patent_app_number] => 10576818
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/576818 | Nucleic acids useful for triggering tumor cell lethality | Oct 24, 2004 | Issued |
Array
(
[id] => 5667575
[patent_doc_number] => 20060172925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-03
[patent_title] => 'Thio-siRNA aptamers'
[patent_app_type] => utility
[patent_app_number] => 10/968574
[patent_app_country] => US
[patent_app_date] => 2004-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 19922
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20060172925.pdf
[firstpage_image] =>[orig_patent_app_number] => 10968574
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/968574 | Thio-siRNA aptamers | Oct 18, 2004 | Abandoned |
Array
(
[id] => 5656491
[patent_doc_number] => 20060142227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-29
[patent_title] => 'Amphiphylic peptide-PNA conjugates for the delivery of PNA through the blood brain barrier'
[patent_app_type] => utility
[patent_app_number] => 10/962669
[patent_app_country] => US
[patent_app_date] => 2004-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7006
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20060142227.pdf
[firstpage_image] =>[orig_patent_app_number] => 10962669
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/962669 | Amphiphylic peptide-PNA conjugates for the delivery of PNA through the blood brain barrier | Oct 12, 2004 | Abandoned |
Array
(
[id] => 7005064
[patent_doc_number] => 20050170377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-04
[patent_title] => 'Regulation of bcl-2 gene expression'
[patent_app_type] => utility
[patent_app_number] => 10/961458
[patent_app_country] => US
[patent_app_date] => 2004-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 14871
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20050170377.pdf
[firstpage_image] =>[orig_patent_app_number] => 10961458
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/961458 | Regulation of bcl-2 gene expression | Oct 6, 2004 | Issued |
Array
(
[id] => 5096160
[patent_doc_number] => 20070117769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-24
[patent_title] => 'Methods of modulating cell cycle and cell signaling pathways using biliverdin reductase'
[patent_app_type] => utility
[patent_app_number] => 10/584886
[patent_app_country] => US
[patent_app_date] => 2004-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 41404
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20070117769.pdf
[firstpage_image] =>[orig_patent_app_number] => 10584886
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/584886 | Methods of modulating cell cycle and cell signaling pathways using biliverdin reductase | Sep 28, 2004 | Abandoned |